共 86 条
[1]
Pöss J(2011)Cardiovascular disease and dyslipidemia: beyond LDL Curr Pharm Des 17 861-870
[2]
Custodis F(2008)Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches J Am Coll Cardiol 51 2199-2211
[3]
Werner C(2003)Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis Nature 421 75-79
[4]
Weingärtner O(2010)P2Y13 receptor is critical for reverse cholesterol transport Hepatology 52 1477-1483
[5]
Böhm MLU(2013)Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion Biochim Biophys Acta 1831 719-725
[6]
DeGoma EM(2012)Pancreatic β-cell function relates positively to HDL functionality in well-controlled type 2 diabetes mellitus Atherosclerosis 222 567-573
[7]
DeGoma RL(2011)Overexpression of apolipoprotein O does not impact on plasma HDL levels or functionality in human apolipoprotein A-I transgenic mice Biochim Biophys Acta 1811 294-299
[8]
Rader DJ(1987)Quantitative assessment of atherosclerotic lesions in mice Atherosclerosis 68 231-240
[9]
Martinez LO(2011)Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice Gastroenterology 140 1043-1051
[10]
Jacquet S(2006)Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo Circulation 113 90-97